![]() | ||||||
"weight loss" | ||||||
NEWS | ||||||
EASD: AstraZeneca's Farxiga cuts blood sugar, weight and insulin use in Type 1 study ... daily insulin dose by 8.8%, while patients on the higher dose scored a 3.72% body-weight loss and chopped 13.2% off patients' daily insulin dose.
| ||||||
You have received this email because you have subscribed to Google Alerts. |
![]() |
Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.